Massive drug showdown: can a new pill beat river blindness for good?

NCT ID NCT07145736

First seen Nov 21, 2025

Summary

This study compares two drugs, ivermectin and moxidectin, to see which works better at controlling river blindness and other common infections like intestinal worms and scabies in Angola. Over 52,000 people in 20 village groups will receive one of the drugs once a year for four years. The goal is to find the best way to reduce these diseases in the community and help guide global treatment policies.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HOOKWORM INFECTIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Villages in Andulo and Nharea Municipalities

    RECRUITING

    Andulo, Bíe Province, Angola

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

ascariasis Hookworm Infections hookworm infectious disease onchocerciasis scabies trichuriasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.